OMI-DB Statistics

The OPTIMAM1 project was initiated in 2008, aiming to optimise the adoption of new X-ray technology for detecting breast cancers and thereby to improve the early detection of breast cancers in the NHS Screening Programme. OPTIMAM1 was followed by OPTIMAM2 (2013). The Scientific Computing team, at the Royal Surrey NHS Foundation Trust is responsible for the maintenance of the OPTIMAM Database (OMI-DB), which contains over 8,000,000 processed and unprocessed FFDM, Tomosynthesis and MR images. Screening information is collected from National Breast Screening System (NBSS). Sets of normal, benign and malignant images are selectively collected from multiple NHS sites.

OMI-DB comprises multiple screening datasets (episodes) from multiple clients (cases) who may or may not have been identified with a benign/malignant lesion. Each client's screening dataset contains two views of each breast (medio-lateral oblique and cranio-caudal). Associated tools have been developed to:

  • identify patient cases of interest from the National Breast Screening System (NBSS)
  • automatically retrieve corresponding images from the site’s PACS together with any associated radiological, clinical and pathological data from local databases that may be of interest
  • de-identify collected images
  • allow remote expert radiologists to annotate the images with interesting clinical features and provide descriptors of these features.

All collected cases retrieved from the database are classified as Normal, Benign, Malignant, or Interval Cancers. The Malignant cases are sub-classified into Malignant-Marked and Malignant-Unmarked, depending on if they have been annotated by an OPTIMAM expert image reader or not. The definitions are:

  • Interval Cancer: symptomatic cases in the current year which are classified as malignant after a previous screening appointment at which a client received a normal result and before their next scheduled screening appointment, or previously classified as interval cancer
  • Malignant: cases that are classified as malignant by either surgery, or biopsy, or previously classified as malignant
  • Benign: cases that are classified as benign by either surgery, or biopsy, or previously classified as benign
  • Normal: cases not classified as malignant or benign, or interval cancer

It should be noted that some clients have multiple events in different years.

A high level summary of all data in OMI-DB is given in the table below.

OMI-DB Totals+
Clients844,721
Images11,660,240
Studies2,408,188

Aggregate statistics describing the portion of OMI-DB available for sharing are given in the tables below. These statistics describe the number of clients or episodes for various characteristics of the data.

OMI-DB Totals+
Clients469,359
Images6,998,276
Studies1,311,385
Overall Outcome, Client Count+
Outcome
Benign11,029
Interval Cancers2,860
Malignant15,404
Normal424,339
Unknown15,727
Cancer Type, Client Count+
Cancer type
In-situ4,010
Invasive11,708
Cancer Type, Episode Count+
Cancer type
In-situ4,016
Invasive11,718
Client Age At Screening+
Age
25-292
30-3420
35-3959
40-442,306
45-4964,223
50-54273,303
55-59286,582
60-64261,092
65-69230,764
70-7486,292
75-7914,633
80-844,777
85-89921
90-9487
95-1003
Imaging Modality, Client Count+
Modality
Digital Breast Tomosynthesis only46
Full Field Digital Mammography and Digital Breast Tomosynthesis10,357
Full Field Digital Mammography only458,956
Imaging Modality, Episode Count+
Modality
Digital Breast Tomosynthesis only144
Full Field Digital Mammography and Digital Breast Tomosynthesis10,447
Full Field Digital Mammography only2,064,958
Manufacturer By Year, Episode Count+
Manufacturer2009201020112012201320142015201620172018201920202021202220232024
GE Healthcare22142,8396,0357,8108,2095,3966,8944,6146,7708,4062,7933,013570850
Hologic3217,36283,31768,726112,203149,87492,319144,449105,85877,47775,48218,12539,56413,1629800
Other/Unknown042181455520200000
Philips1299241121111401908900000000
Siemens24,5408,69712,36012,00914,78215,28213,84711,92812,58711,7043,3229,8895,8632,7581,399
Manufacturer, Episode Count+
Manufacturer
GE Healthcare63,805
Hologic1,011,309
Other/Unknown84
Philips1,596
Siemens140,973
Marked Cases By Client Outcome, Client Count+
Outcome
Benign Marked1,432
Malignant Marked7,160
Prior to Interval Cancer Marked83
Total8,675
Marked Cases By Episode Outcome, Episode Count+
Outcome
Benign Marked1,431
Interval Cancer Marked64
Malignant Marked7,320
Normal Marked146
Prior to Interval Cancer Marked42
Prior to Screen Detected Cancer Marked268
Total9,271
Screening Episode Outcome By Year, Episode Count+
Outcome2009201020112012201320142015201620172018201920202021202220232024
Benign02841,1801,0211,6832,1501,2321,73364954050113323283165
Interval Cancer0010010100000000
Malignant01077861,3271,6951,9061,6851,6861,6901,5691,36847789716880
Normal3521,72793,83484,925129,242169,219110,493162,183120,05895,19394,45924,02152,15119,6323,9111,446
Prior to Interval Cancer1582533924434913742922801951002417000
Prior to Malignant33259761,1041,1751,3091,0821,224998570142157100
Unknown0000010200000000
Screening Episode Outcome, Episode Count+
Outcome
Benign11,392
Interval Cancer3
Malignant15,298
Normal1,175,086
Prior to Interval Cancer2,862
Prior to Malignant8,850
Unknown3
Site, Client Count+
Site
Site 137,268
Site 3681
Site 4103,237
Site 555,444
Site 676,021
Site 776,056
Site 8120,652
Unprocessed And/ Or Processed Screening Images, Client Count+
Processed only258,929
Unprocessed and Processed209,677